Business Weekly - Cambridge, UK

HOME

Asterand's shares go short on Long's resignation

Written by Sam Fountain

Monday, 18 February 2008

Former board member, Long News of a high level resignation has hit the share price of human tissue research firm, Asterand, stripping off over seven per cent. The Royston-based firm announced that its senior independent director, Ron Long, has resigned with immediate effect after seven years with the company. Mr Long joined the board of Pharmagene in February 2001 and continued to serve as senior independent director of the company following the merger with Asterand in January 2006. "We have been very fortunate to benefit from Ron's experience, insight and vision for several years," said Asterand's chairman, David Lee. "He has made a substantial difference to the development of the business.  We wish Ron well for the future." Shares in the company have dipped considerably with the news, losing over seven per cent, or 0.4p to 4.75p. Set as favorite Bookmark Email This Hits: 558 Trackback(0) TrackBack URI for this entry Comments (0) Subscribe to this comment's feed Write comment This content has been locked. You can no longer post any comment.

 

< Prev		Next >